What happened
Butterfly Health Network has raised $250 million in new funds and will soon begin shipping its sub-$2,000, handheld, tablet-connected full-body ultrasound device, Butterfly IQ. Fidelity led the investment, with additional participation from Fosun Pharma, Bill & Melinda Gates Foundation, and Jamie Dinan, along with existing investors. The round brings the company’s total funding...
Artemis Health, which offers a benefit optimization data platform for employers, just received $16 million in Series B funding, led by an investment from F-Prime Capital, the venture capital funds of FMR LLC, the parent company of Fidelity Investments. There was also participation in the round from Maverick Ventures and Kickstart Seed Fund, both previous investors.
This is the second major round...
Adherium, a Melbourne, Australia-based connected inhaler company, has raised $5.9 million ($8 million Australian) through a private placement of shares with Fidelity. Adherium is publicly traded in Australia. Under the deal, Fidelity will purchase 16 million shares at $0.50 Australian per share, bringing the global asset manager's share in the company to 10 percent.
“Fidelity International are...
Late last month we wrote, based on a report from Fortune, that tech saavy up-and-coming health insurer Oscar was raising at least $150 million in a round led by Fidelity. That round is now confirmed, according to Forbes, and it's for more than initially reported: a total of $400 million. The deal reportedly values Oscar at $2.7 billion, just a bit shy of the $3 billion valuation Fortune predicted...
Oscar is raising another round of at least $150 million that could raise its valuation to $3 billion, according to a report over at Fortune. Fidelity is the lead investor, Fortune is reporting.
A digital-saavy upstart health insurer, Oscar has already raised $365 million, including a $32.5 million investment from Google Capital last fall and a $145 million round last spring from Peter Thiel and...
